Integrating Depression Services Into DM Management

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

182 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2011-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this proposal is to integrate depression services into improving adherence for oral hypoglycemic agents so that a single program can assist patients. The investigators hypothesized that patients in the intervention would demonstrate improved adherence to patients' oral hypoglycemic agents and antidepressants as well as improved clinical outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Web-Based Collaborative Care for Patients With Diabetes and Depression

NCT01985711

Diabetes Mellitus, Type 2 Depression

UNKNOWN NA

Participatory Design of Patient-centered Depression and Diabetes Care

NCT02178176

Depression Type 2 Diabetes Mellitus

COMPLETED NA

Improving Medication Adherence in Comorbid Conditions

NCT00072891

Diabetes Mellitus, Type 2 Hypertension Hyperlipidemia

COMPLETED NA

A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care

NCT00939250

Type 2 Diabetes Major Depressive Disorder

COMPLETED PHASE4

The Diabetes Medication Adherence Promotion Intervention Trial

NCT02458495

Diabetes Mellitus, Type 2

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Many older patients do not take their medications for Type 2 diabetes mellitus (DM) as prescribed by their physician. Depression is common among patients with Type 2 DM and may be the reason why patients do not take their medications as prescribed. A program in which Type 2 DM and depression are treated together in primary care would improve the health of older patients with both Type 2 diabetes and depression and would be practical in real world practices with competing demands for limited resources. There is an urgent need for research that can bring potentially life-extending strategies to older patients with both diabetes and depression. People can better control their Type 2 DM if they treat their depression and the same strategies can be used to help patients take their medications for both conditions. In this program patients were involved in identifying problems with taking their medicines and working on solutions. The aims of this program were to improve how patients take their medications for Type 2 DM and depression as well as blood glucose control and symptoms of depression over 3 months. To see whether this program works the investigators compared the results of patients receiving this program to those who do not receive the program. Findings may lead to the development of other programs in which depression and chronic medical conditions are treated together.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Mellitus Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adherence Intervention

Factors affecting adherence to oral hypoglycemic agents and antidepressants were addressed using a problem solving process.

Group Type EXPERIMENTAL

Adherence Intervention

Intervention Type BEHAVIORAL

Factors affecting adherence are addressed using a problem solving process.

Usual Care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adherence Intervention

Factors affecting adherence are addressed using a problem solving process.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 30 years and older
* a current diagnosis of Type 2 DM
* current prescription for an oral hypoglycemic agent
* current prescription for an antidepressant
* able to communicate in English
* willing to give informed consent.

Exclusion Criteria

* inability to give informed consent
* significant cognitive impairment at baseline (Mini-Mental State Examination (MMSE) \<21)
* residence in a care facility that provides medications
* unwillingness or inability to use the Medication Event Monitoring System

Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No